Ohtani I, Ohtsuki K, Aikawa T, Sato Y, Anzai T, Ouchi J
Auris Nasus Larynx. 1984;11(3):119-24. doi: 10.1016/s0385-8146(84)80019-x.
The purpose of this study was to clarify the mechanism of the protective effect of fosfomycin (FOM) against inner ear damage induced by an aminoglycoside dibekacin (DKB), when administered concurrently DKB and FOM. Rats were treated with 50 mg/kg of DKB with or without 500 mg/kg of FOM for short-term administration. No significant difference was seen in the serum peak level and in the area under the curve between the group receiving DKB alone and the combined administration group of DKB and FOM. On the other hand, the DKB level in the kidney was significantly lower in the combined administration group than in the group receiving DKB alone. The mechanism of protective effect of FOM against DKB-induced ototoxicity may be considered as follows: FOM inhibits the accumulation of DKB in the kidney and reduces its concentration in the kidney and serum. Consequently, the transferability of DKB into the inner ear is decreased, and finally inner ear damage is reduced.
本研究的目的是阐明在同时给予双去氧卡那霉素(DKB)和磷霉素(FOM)时,磷霉素对DKB所致内耳损伤的保护作用机制。大鼠短期给予50mg/kg的DKB,同时或不同时给予500mg/kg的FOM。单独给予DKB组与DKB和FOM联合给药组之间,血清峰值水平和曲线下面积未见显著差异。另一方面,联合给药组肾脏中的DKB水平显著低于单独给予DKB组。FOM对DKB诱导的耳毒性的保护作用机制可能如下:FOM抑制DKB在肾脏中的蓄积,降低其在肾脏和血清中的浓度。因此,DKB向内耳的转移能力降低,最终内耳损伤减轻。